Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
1st World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies : Portorož, Slovenia, September 6 –10, 2015 / / edited by Tomaz Jarm, Peter Kramar
| 1st World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies : Portorož, Slovenia, September 6 –10, 2015 / / edited by Tomaz Jarm, Peter Kramar |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (445 p.) |
| Disciplina | 610.28 |
| Collana | IFMBE Proceedings |
| Soggetto topico |
Biomedical engineering
Electroporation Cell physiology Microbiology Biophysics Pharmaceutical technology Biomedical Engineering and Bioengineering Cell Physiology Food Microbiology Biological and Medical Physics, Biophysics Pharmaceutical Sciences/Technology |
| ISBN | 981-287-817-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Preface; Satellite Events Incorporated in WC2015; Committees; Sponsors; Table of Contents; Invited Plenary Lectures; About the First Industrial Scale PEF - Plants and Heinz Doevenspeck'sRole - A Historical Review; I. INTRODUCTION; II. DOEVENSPECK`S PROJECTSFROM 1958 UNTIL 1983; III. COOPERATION DOEVENSPECK- KRUPP UNTIL 1993; Harnessing the Structure Modifying Potential of Pulsed ElectricFields (PEF) - Food Processing Examples in Product Stabilization,Process Acceleration and Compound Extraction; I. INTRODUCTION; II. CASE STUDY 1: PEFIN HURDLE PRESERVATION
III. CASE STUDY 2: PEF IN SPOREINACTIVATIONIV. CASE STUDY 3: PEF IN HYDROLYSISTERMINATION; V. CASE STUDY 4: PEF IN WASTEVALORISATION; VI. CASE STUDY 5: PEFIN MEAT TENDERISATION; VII. CASE STUDY 6: PEF IN MEAT CURING; VIII. CONCLUSIONS; Fundamental and Applied Aspects of Pulsed Electric Fieldsfor Microbial Inactivation; I. INTRODUCTION; II. BASICS PRINCIPLES OF MICROBIALINACTIVATION BY PULSED ELECTRIC FIELDS; III. FACTORS AFFECTING MICROBIALINACTIVATION BY PULSED ELECTRIC FIELDS; IV. FOOD PRESERVATION BY PULSEDELECTRIC FIELDS How Imaging Molecule Uptake into Cells can Reveal the Mechanismsof Membrane ElectropermeabilizationI. INTRODUCTION; II. MECHANISMS OF MEMBRANEELECTROPERMEABILIZATION AND DNA TRANSFER INTO CELLS.; III. LIPID VESICLES AND 3D CELL CULTURESAS OTHER MODELS TO STUDYELECTROPERMEABILIZATION; IV. CONCLUSIONS; Tissue Reactions to Electroporation and Electrochemotherapy: Vascular Effects that have Implications in Tumor Treatment; I. INTRODUCTION; II. VASCULAR EFFECTS OF ELECTROPORATION; III. VASCULAR EFFECTS OF ELECTROCHEMOTHERAPY; IV. CLINICAL OBSERVATIONS AND IMPLICATIONS; V. CONCLUSIONS Nanosecond Pulses and Beyond - Towards Antenna Applications I. INTRODUCTION; II. NANOSECOND PULSED ELECTRIC FIELD EFFECTS; III. FROM NANOSECOND TOPICO SECOND PULSES; IV. PICO SECOND PULSE GENERATORS; V. BIOELECTRIC EFFECTS OF PICO SECOND PULSED ELECTRIC FIELDS (PSPEF); VI. FROM INVASIVE PULSE DELIVERY SYSTEMS TO ANTENNAS ; VII. CONCLUSION; Optimal Irreversible Electroporation Techniques in the Treatment of LocallyAdvanced Liver and Pancreatic Cancer; I. INTRODUCTION; II. LOCAL TISSUE FACTORS THAT AFFECT IRE; III. TECHNIQUE OF PERFORMING IRE IN LIVERFOR TUMORS WITH VASCULAR PROXIMITY IV. CLINICAL RESULTS OF IRREVERSIBLE ELECTROPORATION FOR HEPATIC MALIGNANCIES Electrotransfer of Antiangiogenic shRNA against Endoglinfor Effective Cancer Treatment; I. VASCULAR TARGETED THERAPIES; II. ENDOGLIN; III. SiRNA AGAINST ENDOGLIN; IV. VASCULAR TARGETED EFFECTS OF shRNAAGAINST ENDOGLIN; V. ANTITUMOR AND ANTIMETASTATICEFFECTS OF shRNA AGAINST ENDOGLIN; VI. COMPLIANCE WITH ETHICAL REQUIREMENTS; VII. CONCLUSIONS; Abiotic Gene Transfer - A Rarity or a Ubiquity?; I. INTRODUCTION; II. DO THE THREE BIOTIC HGT MECHANISMSSUFFICE?; III. LABORATORY HGT TECHNIQUES ARE ALLABIOTIC IV. ABIOTIC HGT MECHANISMS IN NATURE? |
| Record Nr. | UNINA-9910254184803321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
2006 International Conference on Biomedical and Pharmaceutical Engineering
| 2006 International Conference on Biomedical and Pharmaceutical Engineering |
| Pubbl/distr/stampa | Singapore, : Research Publishing |
| Soggetto topico |
Biomedical engineering
Pharmaceutical technology Pharmaceutical biotechnology Drugs - Design |
| ISBN |
9788190426244
81-904262-1-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910873003203321 |
| Singapore, : Research Publishing | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside
| 3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside |
| Autore | Lamprou Dimitrios A. |
| Edizione | [First eddition.] |
| Pubbl/distr/stampa | Newark : , : John Wiley & Sons, Incorporated, , 2024 |
| Descrizione fisica | 1 online resource (265 pages) |
| Disciplina | 615.19 |
| Altri autori (Persone) |
DouroumisDennis
QiSheng |
| Collana | Advances in Pharmaceutical Technology Series |
| Soggetto topico |
Drug delivery systems
Pharmaceutical technology |
| ISBN |
9781119836001
111983600X 9781119835981 1119835984 9781119835998 1119835992 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- 3D Printing of Pharmaceutical and Drug Delivery Devices -- Contents -- About the Editors -- List of Contributors -- Series Preface -- Preface -- 1 Materials for 3D Printing -- 1.1 Introduction -- 1.2 Material Processability Considerations for Pharmaceutical 3DP -- 1.2.1 Thermal Extrusion-Based 3D Printing -- 1.2.1.1 Thermal Considerations -- 1.2.1.2 Solubility Enhancement -- 1.2.1.3 Mechanical Considerations -- 1.2.2 Semi-Solid Extrusion 3DP -- 1.2.2.1 Rheological Considerations -- 1.2.2.2 Example Applications -- 1.2.3 Powder Bed Fusion 3D Printing -- 1.2.3.1 Powder Flowability Considerations -- 1.2.3.2 Powder Packing Density Considerations -- 1.2.3.3 Powder Energy Absorbance Considerations -- 1.2.4 Stereolithography 3D Printing -- 1.3 Classification of Common Materials Used in Pharmaceutical 3DP -- 1.3.1 Alcohol Derived Polymers -- 1.3.2 Eudragits -- 1.3.3 Other Polymers -- 1.3.4 Graft Polymers -- 1.3.5 Photocrosslinkable -- 1.3.6 Natural Materials -- 1.3.7 Lipid Materials -- 1.4 Conclusions and Future Perspectives -- References -- 2 The Use of Microstructure Design and 3D Printing for Tailored Drug Release -- 2.1 Introduction -- 2.2 3D-Printing Technologies -- 2.3 3D Design for Drug-Loaded Device -- 2.3.1 CAD Design-Based Design -- 2.3.2 Computational Software-Based Design -- 2.3.3 3D-Printing Parameter-Based Design -- 2.3.4 Polypills and Complex Designs -- 2.4 3D Designs Influence Drug Release -- 2.4.1 Controlling Drug Release -- 2.4.2 Modifying Drug Release -- 2.5 Challenges and Perspective -- References -- 3 3D Printing of Oral Solid Dosage Forms Using Selective Laser Sintering -- 3.1 Introduction -- 3.2 Operational Principles of Selective Laser Sintering -- 3.2.1 Manufacturing Challenges for SLS -- 3.2.2 Laser Selection and Scanning Speed -- 3.2.3 Powder Material Parameters -- 3.2.4 Powder Bed and Recoater Parameters.
3.3 3D-Printed Oral Dosages -- 3.4 Advantages of SLS -- 3.4.1 Printing Features -- 3.4.2 Control of Surface Properties -- 3.4.3 Printing of Complex Geometries -- 3.4.4 Using a Wide Range of Materials -- 3.4.5 Drug Loading and Dose Combinations -- 3.4.6 Personalised Dosage Forms -- 3.4.7 SLS Disadvantages -- 3.5 Conclusions -- References -- 4 3D Printing for Medical Device Applications -- 4.1 Introduction -- 4.2 3D Printers -- 4.2.1 SLA -- 4.2.2 FFF -- 4.2.3 Selective Laser Sintering (SLS) -- 4.3 Biomaterials for 3D-Printed Medical Devices -- 4.3.1 Bioresorbable Polymers -- 4.3.1.1 Synthetic Bioresorbable Polymers -- 4.3.1.2 Natural Bioresorbable Polymers -- 4.3.2 Non-Bioresorbable Polymers -- 4.3.3 Smart Polymers -- 4.3.4 Metal and Ceramic -- 4.4 3D-Printed Personalised Medical Devices -- 4.4.1 Vascular Repair Devices -- 4.4.2 Splints -- 4.4.3 Nerve Guidance Conduits -- 4.4.4 Tissue Engineering -- 4.4.5 3D Printing in Dentistry -- 4.4.6 3D-Printed Orthopaedic Devices -- 4.5 Regulatory -- 4.6 Future Perspectives -- References -- 5 3D Printed Implants for Long-Acting Drug Delivery -- 5.1 Introduction -- 5.2 Types of 3D-Printed Scaffolds -- 5.2.1 Implantable Scaffolds -- 5.2.1.1 Passive Implants -- 5.2.1.2 Active Implants -- 5.2.2 Injectable Scaffolds -- 5.2.3 Innovative 3D-Printed Scaffolds -- 5.3 Critical Parameters in Designing 3D-Printed Implantable Scaffolds -- 5.3.1 Structural Characteristics -- 5.3.1.1 Geometry of Implants -- 5.3.1.2 Porosity Properties and Pore Features -- 5.3.1.3 Surface Properties -- 5.3.2 Mechanical Properties -- 5.3.3 Biological and Physiological Parameters -- 5.3.3.1 Cellular Adhesion -- 5.3.3.2 Absorption and Degradation Rates -- 5.3.3.3 Biocompatibility Aspects -- 5.4 Critical Parameters in Selecting Materials for 3D-Printed Scaffolds -- 5.4.1 Materials Used in 3D-Printed Long-Acting Scaffolds -- 5.4.1.1 Natural Polymers. 5.4.1.2 Synthetic Polymers -- 5.4.1.3 Ceramics and Metals -- 5.4.1.4 Composites -- References -- 5.5 Manufacturing Techniques for Implantable Scaffolds -- 5.5.1 Hot-Melt Extrusion -- 5.5.2 Compression -- 5.5.3 Injection Moulding -- 5.5.4 Solvent Casting -- 5.5.5 3D Printing -- 5.5.6 Scale-Up in 3D-Printing Process for the Manufacturing of Scaffolds -- 5.6 Drug Release Mechanism of Long-Acting 3D-Printing Polymeric Implantable Systems -- 5.7 Outlining Regulatory Framework for 3D-Printed Implantable Scaffolds -- 5.7.1 Commercial Implantable Scaffolds -- 5.8 Conclusions -- References -- 6 Wound Dressings by 3D Printing -- 6.1 Wound Healing Process -- 6.1.1 Haemostasis/Coagulation -- 6.1.2 Inflammation -- 6.1.3 Proliferation -- 6.1.4 Re-epithelisation/Remodelling -- 6.1.5 Wound Classification -- 6.1.6 Wound Dressings -- 6.1.7 3D Printing -- 6.1.8 3D-Printed Dressings -- 6.2 Case Studies -- 6.3 Summary/Conclusions -- References -- 7 3D Printing of Hydrogels -- 7.1 Introduction -- 7.2 Applications of 3D-Printed Hydrogels -- 7.2.1 Tissue Engineering -- 7.2.2 Wound Healing -- 7.2.3 Drug Delivery -- 7.3 Types of Hydrogel Materials for 3D Printing -- 7.3.1 Natural Polymers -- 7.3.2 Synthetic Polymers -- 7.3.3 Natural-Synthetic Hybrid Polymers -- 7.3.4 Ionically Charged Polymers -- 7.3.5 Crosslinked Polymers -- 7.3.6 Method of Hydrogel Preparation -- 7.4 3D Printing Techniques for Hydrogels -- 7.4.1 Laser-Based 3D Printing -- 7.4.1.1 Stereolithography -- 7.4.1.2 Two-Photon Polymerisation -- 7.4.1.3 Laser-Induced Forward Transfer -- 7.4.2 Extrusion-Based Printing -- 7.4.3 Inkjet-Based Printing -- 7.5 Printability and Printing Parameters -- 7.5.1 Bioink Design -- 7.5.1.1 Materials Selection, Concentration and Viscosity -- 7.5.1.2 Rheological Properties -- 7.5.1.3 Shear-Thinning -- 7.5.1.4 Viscoelasticity and Yield Stress -- 7.5.1.5 Cell Encapsulation. 7.5.2 Crosslinking Techniques -- 7.5.2.1 Thermal Crosslinking -- 7.5.2.2 Physical Ionic Crosslinking -- 7.5.2.3 Chemical Crosslinking -- 7.5.2.4 Photocrosslinking -- 7.5.3 3D Printing Parameters -- 7.5.3.1 Temperature -- 7.5.3.2 Pressure -- 7.5.3.3 Speed -- 7.6 Clinical Translation -- 7.6.1 Regulatory Considerations -- 7.6.2 Manufacturing Considerations -- 7.6.3 Limitations and Future Direction -- 7.7 Conclusions -- References -- 8 Analytical Characterisation of 3D-Printed Medicines -- 8.1 Introduction -- 8.2 Preformulation -- 8.2.1 Thermal Analysis -- 8.2.2 X-Ray Powder Diffraction (XRPD) -- 8.2.3 Infrared Spectroscopy -- 8.2.4 Hot-Stage Microscopy (HSM) -- 8.2.5 Customizsd Sample Preparation for the Preformulation Protocol -- 8.3 In-Process Characterisations -- 8.3.1 Mechanical Analysis -- 8.3.2 Rheological Analysis -- 8.3.3 Drug Characterisation -- 8.4 Final Product -- 8.4.1 Morphological Analysis -- 8.4.2 X-Ray Computed Microtomography (XμCT) -- 8.4.3 Terahertz Pulsed Imaging (TPI) -- 8.4.4 Mercury Porosimetry -- 8.4.5 Helium Pycnometry -- 8.5 Conclusions -- References -- 9 Adoption of 3D Printing in Pharmaceutical Industry -- 9.1 Partnering and Growing -- 9.2 Regulatory Strategy -- 9.2.1 Product Development -- 9.2.2 Manufacturing -- 9.3 Business Model -- 9.3.1 In-House Pipeline Products -- 9.3.2 Co-Development -- 9.4 Regulatory Strategy -- 9.5 Partnering and Growing -- 9.6 Business Model and Strategy -- 9.6.1 Closing Remarks -- References -- 10 Clinical Benefits of 3D Printing in Healthcare -- 10.1 Introduction -- 10.2 3D Printing Technologies -- 10.2.1 Binder Jetting -- 10.2.2 Vat Photopolymerization -- 10.2.3 Powder Bed Fusion -- 10.2.4 Material Jetting -- 10.2.5 Material Extrusion -- 10.2.5.1 Fused Deposition Modelling -- 10.2.5.2 Semi-Solid Extrusion -- 10.2.5.3 Direct Powder Extrusion -- 10.3 Preclinical Applications of 3D Printing. 10.3.1 Immediate and Modified Release Oral Printlets -- 10.3.2 3D-Printed Drug Delivery Devices for Other Routes of Administration -- 10.4 Clinical Applications of 3D Printing -- 10.4.1 Personalised Medications -- 10.4.2 Improved Acceptability and Medication Compliance -- 10.4.2.1 Paediatric Patients -- 10.4.2.2 Adult and Geriatric Patients -- 10.4.3 Mass Manufacturing -- 10.4.4 Decentralised On-Demand Fabrication -- 10.4.5 Veterinary Applications -- 10.5 Challenges, Regulatory View and Future Applications -- 10.6 Conclusion -- References -- 11 Regulatory Aspects of 3D-Printed Medicinal Products -- 11.1 Introduction -- 11.2 Current Regulatory Framework -- 11.3 Quality Aspects of 3D-Printed Medicinal Products -- 11.4 3D-Printed Paediatric Medicinal Products -- 11.5 3D-Printed Systems With Tailored Release Profiles -- 11.6 Conclusions -- Disclaimer -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910876527503321 |
Lamprou Dimitrios A.
|
||
| Newark : , : John Wiley & Sons, Incorporated, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
3D Printing of Pharmaceuticals / / edited by Abdul W. Basit, Simon Gaisford
| 3D Printing of Pharmaceuticals / / edited by Abdul W. Basit, Simon Gaisford |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (246 pages) |
| Disciplina | 338.476151 |
| Collana | AAPS Advances in the Pharmaceutical Sciences Series |
| Soggetto topico |
Pharmaceutical technology
Biomedical engineering Pharmaceutical Sciences/Technology Biomedical Engineering/Biotechnology |
| ISBN | 3-319-90755-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Paradigm of personalised medicines -- Pharmaceutical ink-jet printing -- Fused-deposition modelling (FDM) 3D printing -- Stereolithographic (SLA) 3D printing -- Selective laser sintering (SLS) 3D printing -- Flexographic 3D printing -- Semi-solid extrusion 3D printing -- Ink-jet printing for personalised dosing -- Printing crystal forms -- Printing of nanoparticle/polymer conjugates -- 3D Printing organ vasculature -- 3D printed ears -- Visualisation of 3D printed compartmental DDSs -- 3D printed medicines - A regulatory perspective -- Spritam – a case study -- 4D printing -- 3DP – costs and manufacturing issues -- Other non-pharmaceutical 3DP areas. |
| Record Nr. | UNINA-9910298395603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The AAPS journal
| The AAPS journal |
| Pubbl/distr/stampa | Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003- |
| Disciplina | 615 |
| Soggetto topico |
Drug delivery systems
Pharmaceutical technology Drugs - Administration Pharmaceutical Preparations Drug Therapy Technology, Pharmaceutical Médicaments - Administration - Dispositifs Techniques pharmaceutiques Médicaments - Administration Tecnologia farmacèutica Dispositius d'administració de medicaments Formes farmacèutiques |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| Soggetto non controllato | Pharmacy, Therapeutics, & Pharmacology |
| ISSN | 1550-7416 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
AAPSJ
American Association of Pharmaceutical Scientists journal |
| Record Nr. | UNISA-996216608703316 |
| Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
The AAPS journal
| The AAPS journal |
| Pubbl/distr/stampa | Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003- |
| Disciplina | 615 |
| Soggetto topico |
Drug delivery systems
Pharmaceutical technology Drugs - Administration Pharmaceutical Preparations Drug Therapy Technology, Pharmaceutical Médicaments - Administration - Dispositifs Techniques pharmaceutiques Médicaments - Administration Tecnologia farmacèutica Dispositius d'administració de medicaments Formes farmacèutiques |
| Soggetto genere / forma |
Periodical
Fulltext Periodicals. Revistes electròniques. |
| ISSN | 1550-7416 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
AAPSJ
American Association of Pharmaceutical Scientists journal |
| Record Nr. | UNINA-9910143514203321 |
| Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
AAPS open
| AAPS open |
| Pubbl/distr/stampa | London, United Kingdom : , : Springer, , [2015]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmaceutical technology
Drugs - Design Farmacologia Revistes electròniques Pharmaceutical Preparations Drug Design Techniques pharmaceutiques Médicaments - Conception Médicaments |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2364-9534 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | American Association of Pharmaceutical Scientists open |
| Record Nr. | UNISA-996217618803316 |
| London, United Kingdom : , : Springer, , [2015]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
AAPS open
| AAPS open |
| Pubbl/distr/stampa | London, United Kingdom : , : Springer, , [2015]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmaceutical technology
Drugs - Design Farmacologia Revistes electròniques Pharmaceutical Preparations Drug Design Techniques pharmaceutiques Médicaments - Conception Médicaments |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2364-9534 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | American Association of Pharmaceutical Scientists open |
| Record Nr. | UNINA-9910137216903321 |
| London, United Kingdom : , : Springer, , [2015]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
AAPS PharmSci
| AAPS PharmSci |
| Pubbl/distr/stampa | Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004 |
| Disciplina | 615 |
| Soggetto topico |
Drug delivery systems
Pharmaceutical technology Drugs - Administration Pharmaceutical Preparations Drug Therapy Technology, Pharmaceutical |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. |
| ISSN | 1522-1059 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996208575503316 |
| Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
AAPS PharmSci
| AAPS PharmSci |
| Pubbl/distr/stampa | Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004 |
| Disciplina | 615 |
| Soggetto topico |
Drug delivery systems
Pharmaceutical technology Drugs - Administration Drugs Chemotherapy Pharmaceutical Preparations Drug Therapy Technology, Pharmaceutical Médicaments - Administration - Dispositifs Techniques pharmaceutiques Médicaments - Administration Systèmes d'administration de médicaments Médicaments Chimiothérapie 44.42 pharmacy, pharmaceuticals |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. |
| ISSN | 1522-1059 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
American Association of Pharmaceutical Scientists PharmSci
PharmSci |
| Record Nr. | UNINA-9910135383503321 |
| Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Pharmaceutical technology
(498)
- Pharmaceutical Sciences/Technology (294)
- Technology, Pharmaceutical (67)
- Pharmacology (60)
- Pharmacy (60)